NetLib Security, a leader in transparent data encryption, today announced the general availability of Encryptionizer Winter 2026, alongside significant upgrades to the Encryptionizer Key Manager (EKM) ...
Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...
With over 30 years’ experience researching, reviewing, and selecting Top Doctors, Castle Connolly is a trusted and credible healthcare research and information company. Our mission is to help people ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果